Dahl Richard R - OmicsDI

Show results for

Unknown (12)
Transcriptomics (2)
Metabolomics (1)

Organisms

Escherichia coli (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (2)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

6520 Q-TOF LC/MS (Agilent) (1)

Publication Date

2015 (1)
2010 (1)
2016 (1)

Metabolite Name

(-)-Epigallocatechin (1)
(.+/-.)-Lyoniresinol 2a-O-.beta.-D-glucopyranoside (1)
(.alpha.S,1S,2R)-.alpha.-Amino-2-carboxycyclopropaneacetic acid (1)
(1-Acetyloxy-3-hydroxy-6,8a-dimethyl-7-oxo-3-propan-2-yl-2,3a,4,8-tetrahydro-1H-azulen-4-yl) 4-hydroxybenzoate (1)
(1-Hydroxycyclohexyl)acetic acid (1)
(12Z)-9,10,11-Trihydroxyoctadec-12-enoic acid (1)
(17Z)-16-(Acetyloxy)-6-hydroxy-4,8,14-trimethyl-3,7-dioxo-18-norcholesta-17,24-dien-21-oic acid (1)
(2E)-N-(4-Acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide (1)
(2E,4E)-5-(6-((.beta.-D-Glucopyranosyloxy)methyl)-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid (1)
(2E,4E)-7,12-Dihydroxy-13-(hydroxymethyl)-3,5,7-trimethyltetradeca-2,4-dienedioic acid (1)
(2E,6E,10E,14S)-14-((2-O-.beta.-D-Glucopyranosyl-.beta.-D-glucopyranosyl)oxy)-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoic acid (1)
(2R,3R,4S,5S,6R)-2-Octoxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol (1)
(2S)-2-[(2R,3S,7R,8R,8aS)-2,3,4'-Trihydroxy-4,4,7,8a-tetramethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrofuro[2,3-e]isoindole]-7'-yl]-3-methylbutanoic acid (1)
(2S)-4-Amino-2-hydroxybutanoic acid (1)
(3-(Hexopyranosyloxy)-2-((2Z)-pent-2-en-1-yl)cyclopentyl)acetic acid (1)
(3.beta.,5.Xi.,8.alpha.,9.beta.,10.alpha.,16.beta.)-16-Hydroxykauran-3-yl .beta.-D-glucopyranoside (1)
(3.beta.,5.Xi.,9.Xi.,18.Xi.)-3,19-Dihydroxyurs-12-ene-24,28-dioic acid (1)
(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8-Hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid (1)
(3S,6R,12S)-6-Benzyl-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone (1)
(4-(.beta.-D-Glucopyranosyloxy)-2,6-bis(3-methylbut-2-en-1-yl)phenyl)(hydroxy)acetic acid (1)
(5-Chloro-1H-benzimidazol-2-yl)methanol (1)
(5.Xi.,9.Xi.,18.Xi.)-3-Oxolup-20(29)-ene-27,28-dioic acid (1)
(7E)-11-Hydroxy-4,5,8,13,13-pentamethyl-3-(2-methylpropyl)-3,3a,4,6a,9,10,11,11a,14a,15-decahydro-1H-[1,3]dioxolo[9,10]oxacyclododecino[2,3-d]isoindole-1,16(2H)-dione (1)
(9Z,12E)-15,16-Dihydroxyoctadeca-9,12-dienoic acid (1)
(E)-1-Hydroxy-2-methylbut-2-enyl 4-diphosphate (1)
(E)-3,10-Dihydroxy-4,9-dimethyldodec-6-enedioic acid (1)
(E)-3-(4-Acetyloxy-2,3-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)prop-2-enoic acid (1)
(E)-4-Hydroxy-4-[4-hydroxy-2-[(E)-6-hydroxyhept-1-enyl]cyclopentyl]but-2-enoic acid (1)
(E)-4-[4-[(E)-Hept-1-enyl]-2,5-dihydroxy-3-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-en-6-yl]-2-methylbut-2-enoic acid (1)
(E)-5-Hydroxyundec-2-enoic acid (1)

Study type

Transcription profiling by array (2)

Release Date

2024 (3)
2015 (2)
2023 (2)
2022 (2)
2010 (1)
2025 (1)
2021 (1)
2018 (1)
2014 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Gene Expression in 70Z/3 pre-B cells Stably Overexpressing Individual members of the mirn23a MiRNA Cluster

Expression of the mirn23a cluster in murine hematopoietic progenitors blocks B cell development. Overexpressed individual cluster members miRs-23a, 24-2, and -27a in 70/3 mouse pre-B cells in order to examine changes in gene expression that would potentially reveal targets of the miRs relevant to h...

ORGANISM(S): Mus musculus

2015-02-12 | E-GEOD-65874 | biostudies-arrayexpress

Functional Genomic Study of Exogenous n-Butanol Stress in Escherichia coli

n-Butanol has been proposed as an alternative biofuel to ethanol, and both Escherichia coli and Saccharomyces cerevisiae have been engineered to produce it. Unfortunately, n-butanol is more toxic than ethanol to these organisms. To understand the basis for its toxicity, cell wide studies were cond...

ORGANISM(S): Escherichia coli

2010-05-16 | E-GEOD-16973 | biostudies-arrayexpress

Metabolomic profiling of Fraxinus excelsior genotypes tolerant or susceptible to ash dieback disease reveals changes in iridoid glycosides

European common ash, Fraxinus excelsior L., is currently threatened by Ash dieback (ADB) caused by the fungus, Hymenoscyphus fraxineus. To detect and identify metabolites that may be products of pathways important in contributing to resistance against H. fraxineus we performed untargeted metabolomic...

2016-11-09 | MTBLS372 | MetaboLights

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.

Not available

S-EPMC4553028 | biostudies-literature

Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.

Not available

S-EPMC11743795 | biostudies-literature

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Not available

S-EPMC4159618 | biostudies-literature

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.

Not available